Donepezil HCl
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Mild to Severe Alzheimer's Disease
Conditions
Mild to Severe Alzheimer's Disease
Trial Timeline
Jan 1, 2008 → Apr 22, 2009
NCT ID
NCT00571064About Donepezil HCl
Donepezil HCl is a approved stage product being developed by Eisai for Mild to Severe Alzheimer's Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00571064. Target conditions include Mild to Severe Alzheimer's Disease.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02097056 | Approved | Completed |
| NCT00571064 | Approved | Completed |
| NCT00188812 | Phase 3 | Completed |
Competing Products
20 competing products in Mild to Severe Alzheimer's Disease